Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prenuvo operates the world’s largest private radiology group focused solely on whole-body MRI. It has performed over 100,000 scans and claims to have alerted up to 5% of patients about potentially life-threatening conditions. The company has presented over 35 papers/abstracts and launched a major clinical trial in July 2024 to assess its care model's impact on outcomes. Its technology enables early detection of hundreds of cancers and conditions without radiation or contrast dye.
Clinical validation for broad population benefit remains under study; the company reports high patient satisfaction (>95%) but faces skepticism from some radiologists regarding cost-effectiveness.Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prenuvo.